Inhaled Long-Acting [beta]2-Agonists Do Not Increase Fatal Cardiovascular Adverse Events in COPD: A...
Inhaled Long-Acting [beta]2-Agonists Do Not Increase Fatal Cardiovascular Adverse Events in COPD: A Meta-Analysis
About this item
Full title
Author / Creator
Xia, Ning , Wang, Hao and Nie, Xiuhong
Publisher
Public Library of Science
Journal title
Language
English
Formats
Publication information
Publisher
Public Library of Science
Subjects
More information
Scope and Contents
Contents
The cardiovascular safety of inhaled long-acting [beta].sub.2 -agonists (LABAs) in patients with chronic obstructive pulmonary disease (COPD) is a controversial problem. Certain studies have suggested that inhaled LABAs lead to an increased risk of cardiovascular events in patients with COPD. This meta-analysis aimed to assess the cardiovascular sa...
Alternative Titles
Full title
Inhaled Long-Acting [beta]2-Agonists Do Not Increase Fatal Cardiovascular Adverse Events in COPD: A Meta-Analysis
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_gale_infotracmisc_A428957956
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A428957956
Other Identifiers
ISSN
1932-6203
E-ISSN
1932-6203
DOI
10.1371/journal.pone.0137904
